FDA Approval Summary: Pembrolizumab for the Treatment of HER2-Positive Gastric Cancer. Casak SJ, Zhang Y, Song C, Mishra-Kalyani PS, et al. Clin Cancer Res 2026 Mar 6:10.1158/1078-0432.CCR-25-3726.

Read + Share

Amedeo Smart

Independent Medical Education

Casak SJ, Zhang Y, Song C, Mishra-Kalyani PS, et al. FDA Approval Summary: Pembrolizumab for the Treatment of HER2-Positive Gastric Cancer. Clin Cancer Res 2026 Mar 6:10.1158/1078-0432.CCR-25-3726.
PMID: 41790455